; (B) make such list publicly available, including by posting such list on the public Web site of the Food and Drug Administration; (C) remove from such list the name of any establishment that fails to register in accordance with this section; and (D) indicate on such list any establishment which has had its registration suspended or cancelled by the Secretary under this section. (2) Application of FOIA (A) Registration documents Any registration documents submitted pursuant to this section shall not be subject to disclosure under section 552 of title 5, United States Code. (B) Other information Information derived from— (i) the list under paragraph (1) ; or (ii) registration documents submitted pursuant to this section, shall not be subject to disclosure under section 552 of title 5, United States Code, except to the extent that such information discloses the identity or location of a specific registrant. (e) Fee schedule A schedule of fees shall be developed by the Secretary to provide for oversight and enforcement of this subchapter. The fee structure shall— (1) be prorated based on the establishment’s gross receipts or sales; and (2) only be assessed on companies with annual gross receipts or sales of cosmetics that exceed $10,000,000. (f) Suspension and cancellation of registration (1) Criteria for suspension Registration under this section is subject to suspension if the Secretary finds— (A) the information submitted by the establishment for registration under subsection (a) is incomplete, inaccurate, or out of date; (B) the establishment fails to notify the Secretary of changes required under subsection (b)(2) ; (C) the establishment fails to pay registration fees, as required under subsection (a) , in a timely manner